Search by Drug Name or NDC

    NDC 17856-8237-01 SENNA 417.12 mg/237mL Details

    SENNA 417.12 mg/237mL

    SENNA is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by ATLANTIC BIOLOGICALS CORP.. The primary component is SENNOSIDES A AND B.

    Product Information

    NDC 17856-8237
    Product ID 17856-8237_659979e0-fa30-43ee-8920-e64f979838d1
    Associated GPIs 46200060201220
    GCN Sequence Number 002922
    GCN Sequence Number Description sennosides SYRUP 8.8MG/5ML ORAL
    HIC3 D6S
    HIC3 Description LAXATIVES AND CATHARTICS
    GCN 08660
    HICL Sequence Number 001289
    HICL Sequence Number Description SENNOSIDES
    Brand/Generic Generic
    Proprietary Name SENNA
    Proprietary Name Suffix n/a
    Non-Proprietary Name SENNA
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 417.12
    Active Ingredient Units mg/237mL
    Substance Name SENNOSIDES A AND B
    Labeler Name ATLANTIC BIOLOGICALS CORP.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part334
    Listing Certified Through 2023-12-31

    Package

    NDC 17856-8237-01 (17856823701)

    NDC Package Code 17856-8237-1
    Billing NDC 17856823701
    Package 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-8237-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-8237-6)
    Marketing Start Date 2020-05-04
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 8b7cc0d5-029b-43f7-a050-8771e7db4551 Details

    Revised: 6/2022